Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Sep. 13, 1996

No Comments

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

No Comments

New cholinergic channel activators described by Abbott

Sep. 13, 1996

No Comments

Inhibitors of C1r for Alzheimer's disease

Sep. 13, 1996

No Comments

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Sep. 13, 1996

No Comments

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Sep. 13, 1996

No Comments

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

No Comments

Antiangiogenic eponemycin analogues

Sep. 13, 1996

No Comments

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

No Comments

A new class of selective COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

New compound, BioWorld Science
RSS

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Potential antiasthmatic agent from Lipha

New cholinergic channel activators described by Abbott

Inhibitors of C1r for Alzheimer's disease

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Dolastatin 10 mimic dolaphenine androstane

Antiangiogenic eponemycin analogues

Dual TNF production and PDE IV inhibitor from Pfizer

A new class of selective COX-2 inhibitors from Merck Frosst

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

New compound, BioWorld Science RSS

New compound, BioWorld Science
RSS